InvestorsHub Logo

JWC3

10/16/22 10:55 AM

#378082 RE: Gator328 #378079

Pretty negative. Everyone is anticipating a new ANAVEX, different from big pharma drugs that dehabilitate, instead, rehabilitate!

On A 2-73, most will end their mental decline and some will even improve, and some will return to complete mental health!

As with the big pharma drugs, which only remove A-Beta, folks expect negative outcomes, the expectation is brain swelling and bleeding and nothing positive!!

I believe AVXL price will move up even before approval.

growingpain

10/16/22 12:36 PM

#378095 RE: Gator328 #378079

Oh, if the results are as good as some people here expect, there is absolutely "no sell the news," especially if the run is as slight as you expect. We are talking about AD here, not a rare disease or a disease with plenty of alternative options. Check BIIB after the most recent readout for the potential value-added from a drug with a good AD P3 in the bag. Your theory may be good in justifying your holdings, but no way it is realised upon positive results.